Human Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021)

National Institute for Health and Welfare

The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter "THL" or “Customer”) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is one year (during 2019-2020). The extend of the contract (option period) is one year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The Customer will choose the Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract. Please note that all times given in the Invitation to tender are local time in Finland. Tender annexes: Annex 1 Contract Annex 2 JYSE 2014 Supplies (link).

Määräaika

Tarjousten vastaanottamisen määräaika oli 2018-12-12. Hankinta julkaistiin 2018-11-05.

Toimittajat

Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:

• GlaxoSmithKline Oy

Kuka?

• National Institute for Health and Welfare

Mitä?

• Systeemisesti vaikuttavat infektiolääkkeet › Rokotteet

Missä?

• Manner-Suomi › Helsinki-Uusimaa

Hankintojen historia

Päivämäärä	Asiakirja
2018-11-05	hankintailmoitus
2019-04-23	Ilmoitus tehdystä sopimuksesta
2019-06-12	Ilmoitus tehdystä sopimuksesta

hankintailmoitus (2018-11-05)
Kohde
Hankinnan laajuus
Otsikko: Rokotteet
Viitenumero: THL/1722/8.00.02/2018
Lyhyt kuvaus:

Ilmoituksen metatiedot
Alkukieli: englanti 🗣️
Asiakirjatyyppi: hankintailmoitus
Sopimuksen luonne: Tavarat
Asetus: Euroopan unioni ja WTO-maat
Yhteinen hankintanimikkeistö (CPV)
Koodi: Rokotteet 📦
Suorituspaikka
NUTS-alue: Suomi/Finland 🏙️

Menettely
Menettelyn tyyppi: Avoin menettely
Tarjouksen tyyppi: Tarjous koskee kaikkia eriä
Myöntämisperusteet
Alin hinta

Hankintaviranomainen
Tunnistetiedot
Maa: Suomi 🇫🇮
Hankintaviranomaisen tyyppi: Kansallinen tai liittovaltiotason virasto/laitos
Hankintaviranomaisen nimi: National Institute for Health and Welfare
Postiosoite: PL 30
Postinumero: 00271
Postitoimipaikka: Helsinki
Yhteystiedot
Internetosoite: https://thl.fi/en/web/thlfi-en 🌏
Sähköposti: jenni.tiainen@thl.fi 📧
Asiakirjojen URL-osoite: https://hanki.tarjouspalvelu.fi/hanki 🌏
Osallistumisen URL-osoite: https://hanki.tarjouspalvelu.fi/hanki?id=203386&tpk=7c494ede-32cd-4e27-817c-36605c974f83 🌏

Viite
Päivämäärät
Lähetyspäivä: 2018-11-05 📅
Tarjousten jättämisen määräaika: 2018-12-12 📅
Julkaisupäivä: 2018-11-07 📅
Tunnisteet
Ilmoituksen numero: 2018/S 214-489934
EUVL-S-numero: 214
Lisätietoja

This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA advertisement website as well as this Invitation to tender and its Annexes.

Kohde
Hankinnan laajuus
Lyhyt kuvaus:

The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM´s side. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Invitation to Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. Contract period estimated quantity for the contract period is 47 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The estimated duration of the contract is about 1 year. The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Information about additional procurement options". Please notice that in the section "II.2.5. Award criteria" Price means the reference price. Tenders will be compared in the manner described in section "Grounds for decision" of the Invitation to tender.

Kesto: 12 kuukautta
Uudistusten kuvaus:

The Customer reserves the right to extend the contract for 1 year (during 2020-2021). Estimated quantity for the option period is 47 000 doses (+/- 20 %).

Lisätietoja:

Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot
Osallistumisehdot
Kelpoisuus harjoittaa ammattitoimintaa:

Please see sections Other information of the call for tenders and the European Single Procurement Document (ESPD).

Sopimuksen toteuttaminen
Sopimuksen täytäntöönpanoehdot:

Please see sections Other information of the call for tenders and the European Single Procurement Document (ESPD).

Menettely
Oikeusperusta: 32014L0024
Tarjousten vastaanottoaika: 12:00
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Tarjouksen voimassaoloaika: 6 kuukautta
Tarjousten avauspäivä: 2018-12-12 📅
Tarjousten avausaika: 13:00
Paikka: The opening of the tenders is not a public event.

Hankintaviranomainen
Tunnistetiedot
Kansallinen rekisterinumero: 2229500-6
Yhteystiedot
Asiakirjojen URL-osoite: https://hanki.tarjouspalvelu.fi/hanki 🌏

Viite
Lisätietoja

Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the invitation to tender are local time in Finland. Please note that the online connection to the Supplier Portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.

Täydentävät tiedot
Arvostelurunko
Nimi: The Market Court
Postiosoite: Radanrakentajantie 5
Postitoimipaikka: Helsinki
Postinumero: 00520
Maa: Suomi 🇫🇮
Puhelin: +358 295643300 📞
Sähköposti: markkinaoikeus@oikeus.fi 📧
Faksi: +358 295643314 📠
Internetosoite: http://www.markkinaoikeus.fi/en/index.html 🌏
Lähde: OJS 2018/S 214-489934 (2018-11-05)

Ilmoitus tehdystä sopimuksesta (2019-04-23)
Kohde
Hankinnan laajuus
Viitenumero: STM/37/2018
Lyhyt kuvaus:

The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter “THL” or “Customer”) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is 1 year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract. Please note that all times given in the Invitation to tender are local time in Finland. Tender annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (link).

Hankinnan kokonaisarvo: 1 447 600 EUR 💰
Ilmoituksen metatiedot
Asiakirjatyyppi: Ilmoitus tehdystä sopimuksesta

Menettely
Tarjouksen tyyppi: Ei sovelleta

Viite
Päivämäärät
Lähetyspäivä: 2019-04-23 📅
Julkaisupäivä: 2019-04-24 📅
Tunnisteet
Ilmoituksen numero: 2019/S 080-191763
Viittaa ilmoitukseen: 2018/S 214-489934
EUVL-S-numero: 80
Lisätietoja

This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA advertisement website as well as this invitation to tender and its annexes.

Kohde
Hankinnan laajuus
Lyhyt kuvaus:

The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM's side. The roles of STM and Customer are described in more detail in section “Presentation of the Contracting Authority”. The contract will be awarded to 1 supplier based on a comparison of tenders. Estimated quantity for the contract period is 47 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The estimated duration of the contract is about 1 year. After the contract period, the customer reserves the right for the option described in section “Information about additional procurement options”. Please notice that in the Section “II.2.5) Award criteria” price means the reference price. Tenders will be compared in the manner described in section “Grounds for decision” of the invitation to tender.

Lisätietoja:

Sopimuksen tekeminen
Sopimuksen tekemispäivä: 2019-03-25 📅
Nimi: GlaxoSmithKline Oy
Kansallinen rekisterinumero: FI01083784
Postitoimipaikka: Espoo
Maa: Suomi 🇫🇮
Helsinki-Uusimaa 🏙️
Hankinnan kokonaisarvo: 1 447 600 EUR 💰
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 2
Lähde: OJS 2019/S 080-191763 (2019-04-23)

Ilmoitus tehdystä sopimuksesta (2019-06-12)
Kohde
Hankinnan laajuus
Lyhyt kuvaus:

The Ministry of Social Affairs and Health (hereinafter ‘STM’) and National Institute for Health and Welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is one year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract.

Hankinnan kokonaisarvo: 1 447 600 EUR 💰

Viite
Päivämäärät
Lähetyspäivä: 2019-06-12 📅
Julkaisupäivä: 2019-06-13 📅
Tunnisteet
Ilmoituksen numero: 2019/S 112-274817
EUVL-S-numero: 112
Lisätietoja

This procurement is detailed in the Contract Notice published on TED (Tenders Electronic Daily) online version and on the HILMA advertisement website as well as this Invitation to tender and its Annexes.

Kohde
Hankinnan laajuus
Lyhyt kuvaus:

The purpose of STM and the customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM's side. The roles of STM and customer are described in more detail in section ‘Presentation of the Contracting Authority’. The subject of procurement and the mandatory requirements relating to it are described in detail in this invitation to tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. Contract period: the contract period is 1 year (during 2019-2020). The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. Please notice that in the Section ‘II.2.5. Award criteria’ Price means the reference price. Tenders will be compared in the manner described in section ‘Grounds for decision’ of the invitation to tender.

Vaihtoehtojen kuvaus:

If the customer decides to exercise the option, the supplier is committed to the following extensions of the contract: The extend of the contract (option period) is 1 year (during 2020-2021).

Lisätietoja:

Sopimuksen tekeminen
Kansallinen rekisterinumero: 01083784

Viite
Lisätietoja

Tenderers may ask clarification questions using the supplier portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the invitation to tender are local time in Finland. Please note that the online connection to the supplier portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.

Lähde: OJS 2019/S 112-274817 (2019-06-12)

Uudet hankinnat asiaan liittyvissä luokissa 🆕

Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet (>20 uudet hankinnat)

Farmaseuttiset tuotteet (9)

Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit

Systeemisesti vaikuttavat infektiolääkkeet

Rokotteet